| UniProt ID | NEUR3_HUMAN | |
|---|---|---|
| UniProt AC | Q9UQ49 | |
| Protein Name | Sialidase-3 | |
| Gene Name | NEU3 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 428 | |
| Subcellular Localization |
Cell membrane Peripheral membrane protein . |
|
| Protein Description | Plays a role in modulating the ganglioside content of the lipid bilayer at the level of membrane-bound sialyl glycoconjugates.. | |
| Protein Sequence | MEEVTTCSFNSPLFRQEDDRGITYRIPALLYIPPTHTFLAFAEKRSTRRDEDALHLVLRRGLRIGQLVQWGPLKPLMEATLPGHRTMNPCPVWEQKSGCVFLFFICVRGHVTERQQIVSGRNAARLCFIYSQDAGCSWSEVRDLTEEVIGSELKHWATFAVGPGHGIQLQSGRLVIPAYTYYIPSWFFCFQLPCKTRPHSLMIYSDDLGVTWHHGRLIRPMVTVECEVAEVTGRAGHPVLYCSARTPNRCRAEALSTDHGEGFQRLALSRQLCEPPHGCQGSVVSFRPLEIPHRCQDSSSKDAPTIQQSSPGSSLRLEEEAGTPSESWLLYSHPTSRKQRVDLGIYLNQTPLEAACWSRPWILHCGPCGYSDLAALEEEGLFGCLFECGTKQECEQIAFRLFTHREILSHLQGDCTSPGRNPSQFKSN | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 23 | Phosphorylation | QEDDRGITYRIPALL CCCCCCCCEEECEEE | 15.01 | - | |
| 24 | Phosphorylation | EDDRGITYRIPALLY CCCCCCCEEECEEEE | 12.48 | - | |
| 31 | Phosphorylation | YRIPALLYIPPTHTF EEECEEEEECCCHHH | 16.54 | - | |
| 35 | Phosphorylation | ALLYIPPTHTFLAFA EEEEECCCHHHHHHH | 28.35 | - | |
| 44 | Ubiquitination | TFLAFAEKRSTRRDE HHHHHHHHHCCCCCH | 48.49 | - | |
| 74 | Ubiquitination | LVQWGPLKPLMEATL EEECCCCHHHEECCC | 38.96 | - | |
| 77 | Ubiquitination | WGPLKPLMEATLPGH CCCCHHHEECCCCCC | 4.46 | - | |
| 107 | Ubiquitination | VFLFFICVRGHVTER EEEEEEEECCCCCCH | 7.59 | - | |
| 154 | Ubiquitination | EVIGSELKHWATFAV HHHCHHHHCEEEEEE | 32.80 | - | |
| 171 | Phosphorylation | GHGIQLQSGRLVIPA CCCEEECCCCEEEEC | 34.18 | 26074081 | |
| 179 | Phosphorylation | GRLVIPAYTYYIPSW CCEEEECEEEEECCE | 7.01 | 26074081 | |
| 180 | Phosphorylation | RLVIPAYTYYIPSWF CEEEECEEEEECCEE | 16.38 | 26074081 | |
| 181 | Phosphorylation | LVIPAYTYYIPSWFF EEEECEEEEECCEEE | 6.16 | 26074081 | |
| 182 | Phosphorylation | VIPAYTYYIPSWFFC EEECEEEEECCEEEE | 9.88 | 26074081 | |
| 187 | Ubiquitination | TYYIPSWFFCFQLPC EEEECCEEEEEECCC | 4.48 | - | |
| 241 | Phosphorylation | RAGHPVLYCSARTPN CCCCEEEEEECCCCC | 5.65 | 21945579 | |
| 243 | Phosphorylation | GHPVLYCSARTPNRC CCEEEEEECCCCCCC | 13.76 | 21945579 | |
| 269 | Phosphorylation | GFQRLALSRQLCEPP HHHHHHHHHCCCCCC | 16.63 | 24719451 | |
| 298 | Phosphorylation | IPHRCQDSSSKDAPT CCCCCCCCCCCCCCC | 15.61 | 27251275 | |
| 299 | Phosphorylation | PHRCQDSSSKDAPTI CCCCCCCCCCCCCCC | 50.09 | 27251275 | |
| 300 | Phosphorylation | HRCQDSSSKDAPTIQ CCCCCCCCCCCCCCC | 38.21 | 27251275 | |
| 301 | Ubiquitination | RCQDSSSKDAPTIQQ CCCCCCCCCCCCCCC | 60.91 | - | |
| 302 | Phosphorylation | CQDSSSKDAPTIQQS CCCCCCCCCCCCCCC | 60.78 | 24719451 | |
| 305 | Phosphorylation | SSSKDAPTIQQSSPG CCCCCCCCCCCCCCC | 32.89 | 27732954 | |
| 309 | Phosphorylation | DAPTIQQSSPGSSLR CCCCCCCCCCCCCEE | 23.33 | 30278072 | |
| 310 | Phosphorylation | APTIQQSSPGSSLRL CCCCCCCCCCCCEEE | 29.01 | 30278072 | |
| 313 | Phosphorylation | IQQSSPGSSLRLEEE CCCCCCCCCEEEEEC | 29.59 | 30108239 | |
| 314 | Phosphorylation | QQSSPGSSLRLEEEA CCCCCCCCEEEEECC | 24.35 | 30108239 | |
| 327 | Phosphorylation | EAGTPSESWLLYSHP CCCCCCCEEEEEECC | 27.62 | 30576142 | |
| 331 | Phosphorylation | PSESWLLYSHPTSRK CCCEEEEEECCCCCC | 11.63 | 28796482 | |
| 332 | Phosphorylation | SESWLLYSHPTSRKQ CCEEEEEECCCCCCC | 23.98 | 28796482 | |
| 334 | Ubiquitination | SWLLYSHPTSRKQRV EEEEEECCCCCCCCE | 26.57 | - | |
| 335 | Phosphorylation | WLLYSHPTSRKQRVD EEEEECCCCCCCCEE | 35.42 | 28796482 | |
| 336 | Phosphorylation | LLYSHPTSRKQRVDL EEEECCCCCCCCEEE | 41.76 | 28796482 | |
| 342 | Phosphorylation | TSRKQRVDLGIYLNQ CCCCCCEEEEEECCC | 41.17 | 18691976 | |
| 343 | Phosphorylation | SRKQRVDLGIYLNQT CCCCCEEEEEECCCC | 4.04 | 27251275 | |
| 346 | Phosphorylation | QRVDLGIYLNQTPLE CCEEEEEECCCCCCH | 9.59 | 22817900 | |
| 347 | Phosphorylation | RVDLGIYLNQTPLEA CEEEEEECCCCCCHH | 3.46 | 27251275 | |
| 409 | Phosphorylation | FTHREILSHLQGDCT HHHHHHHHHCCCCCC | 28.01 | 29978859 | |
| 416 | Phosphorylation | SHLQGDCTSPGRNPS HHCCCCCCCCCCCHH | 42.57 | 23401153 | |
| 417 | Phosphorylation | HLQGDCTSPGRNPSQ HCCCCCCCCCCCHHH | 31.52 | 25159151 | |
| 423 | Phosphorylation | TSPGRNPSQFKSN-- CCCCCCHHHHCCC-- | 52.37 | 29978859 | |
| 426 | Methylation | GRNPSQFKSN----- CCCHHHHCCC----- | 41.26 | 82982557 | |
| 426 | Ubiquitination | GRNPSQFKSN----- CCCHHHHCCC----- | 41.26 | - | |
| 450 | Phosphorylation | ----------------------------- ----------------------------- | 24719451 | ||
| 459 | Ubiquitination | -------------------------------------- -------------------------------------- | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of NEUR3_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of NEUR3_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NEUR3_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| GRB2_HUMAN | GRB2 | physical | 12730204 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-417, AND MASSSPECTROMETRY. | |